Neue Suche | Kongressdetail
mail
Druckansicht
 
 

Next Generation Cardiovascular Drug Development Summit

Evvnt Promotion / evvnt
-
25.04.2023 - 27.04.2023  Hyatt Regency Boston, One Ave. de Lafayette, 02111 Boston, Massachusetts, USA
Time: 9:00 am - 4:00 pm
 
Kongressthemen
Are you up to date on the latest research and developments in novel biologics to enhance regenerative and precision cardiovascular therapeutics?

Don't miss the Next Generation Cardiovascular Drug Development Summit, coming to Boston on April 25-27 as the only industry-focused meeting dedicated to leveraging novel cell and gene therapies using mRNA, CRISPR/Cas9 and iPSCs for cardiovascular disease.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
URL:
Brochure: https://go.evvnt.com/1492007-0?pid=4832

Speakers: Christopher O'Donnell, Global Head Cardiovascular and Metabolism Translational Medicine, Novartis Institutes of Biomedical Research, and more.
 

Anfragen und Anmeldung:

https://go.evvnt.com/1492007-1?pid=4832
Frau Nina Podmore
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
Drug Developer - Conference Only: USD 2999.00, Academic and Research - Conference Only: USD 2599.00, Solution Provider - Conference Only: USD 3799.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

European Public Health Association (EUPHA)Swiss Tropical and Public Health InstituteÄrzte der WeltEuropean Health Forum GasteinAMREF - African Medical and Research FoundationAlumni Club Medizinische Universität WienAnästhesie in Entwicklungsländern e. V.Ärztekammer für Wien